Publications by authors named "Danielle Freches"

Claim this Profile
P
Preclinical evaluation of topically-administered PEGylated Fab' lung toxicity.
Danielle Freches, Natacha Rocks, Harshad P Patil, Fabienne Perin, Jacques Van Snick

Int J Pharm X· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation.
Harshad P Patil, Danielle Freches, Linda Karmani, Gregg A Duncan, Bernard Ucakar

J Control Release· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab' antibody fragment after pulmonary delivery in three different species.
Danielle Freches, Harshad P Patil, Maria Machado Franco, Catherine Uyttenhove, Sam Heywood

Int J Pharm· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of B cells in host defense against primary Coxiella burnetii infection.
Laura Schoenlaub, Alexandra Elliott, Danielle Freches, William J Mitchell, Guoquan Zhang

Infect Immun· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils play an important role in protective immunity against Coxiella burnetii infection.
Alexandra Elliott, Laura Schoenlaub, Danielle Freches, William Mitchell, Guoquan Zhang

Infect Immun· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection.
Danielle Freches, Hannelie Korf, Olivier Denis, Xavier Havaux, Kris Huygen

Immunology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice.
Danielle Freches, Marta Romano, Hannelie Korf, Jean-Christophe Renauld, Jacques Van Snick

Clin Vaccine Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis